期刊文献+

抑癌基因PTEN真核表达质粒的构建及对乳腺癌MDA468细胞的影响 被引量:7

Construction of PTEN eukaryotic expression plasmid and its effects on breast carcinoma cell line MDA468
原文传递
导出
摘要 目的 研究外源性PTEN基因稳定转染对人乳腺癌MDA4 6 8细胞体外生长的影响。方法 先构建PTEN基因的真核表达质粒pcDNA3.1 - PTEN ,应用重组质粒pcDNA3.1 - PTEN和pcDNA3.1(- )空载体质粒,以脂质体转染法转染体外培养的人乳腺癌细胞株MDA4 6 8,以未转染组为对照。应用RT PCR、免疫组化和免疫印迹方法分析目的基因及其蛋白表达,MTT法分析细胞生长抑制作用,AnnexinV FITC和PI双染流式细胞术检测细胞凋亡。结果 稳定转染PTEN基因的细胞株有外源目的基因的整合和相应mRNA及其蛋白的高表达。MTT检测表明,pcDNA3.1 - PTEN转染组活细胞数低于未转染组和pcDNA3.1 - MDA4 6 8细胞转染组。流式细胞术显示,pcDNA3.1 - PTEN转染组凋亡率高于未转染组和pcDNA3.1 -MDA4 6 8细胞转染组。结论 外源性PTEN基因稳定转染可抑制人乳腺癌细胞的恶性表型。 Objective To investigate the effects of exogenous wild PTEN gene stably transfection on growth of breast cancer cells in vitro. Methods At first, a recombinant eukaryotic expression plasmid pcDNA3.1-PTEN was constructed. Human breast cancer cell line MDA468 was transfected with pcDNA3.1-PTEN or mock transfected plasmid pcDNA3.1(-) with lipofectamine. RT-PCR, immunohistochemical staining and Western blot were used to determine target gene expression. Cell viability was tested by MTT assay. Apoptosis was determined by flow cytometry with a double-staining method using FITC-conjugated annexin V and PI. Results The PTEN stably transfected cells demonstrated the integration of the exogenous target gene and corresponding mRNA and protein over-expression. There was a significant decline in cell viability of pcDNA3.1-PTEN transfected MDA468 cells in comparison with the mock-transfected ones(P<0.01). The PTEN-trasfected MDA468 cells also showed an increase in the rate of apoptosis, compared with parental and mock-trasfected cells (P<0.001). ConclusionStable expression of exogenous PTEN can suppress the malignant phenotypes of the human breast cancer cell line MDA468.
出处 《中华肿瘤杂志》 CAS CSCD 北大核心 2005年第4期216-219,共4页 Chinese Journal of Oncology
  • 相关文献

参考文献4

二级参考文献41

  • 1Shao Z M,Cancer Res,1998年,58卷,4851页
  • 2Kim J,Cell,1998年,94卷,353页
  • 3邵志敏,中华肿瘤杂志,1997年,19卷,245页
  • 4Kurose K, Zhou XP, Araki T, et al. Frequent loss of PTEN expression is linked to elevated phosphorylated Akt levels, but not associated with p27 and cyclin D1 expression, in primary epithelial ovarian carcinomas. Am J Pathol, 2001,158:2097-2106.
  • 5Depowski PL, Rosenthal SI, Ross JS. Loss of expression of the PTEN gene protein product is associated with poor outcome in breast cancer. Mod Pathol, 2001,14:672-676.
  • 6Porter PL, Malone KE, Heagerty PJ, et al. Expression of cell-cycle regulators p27kip1 and cyclin E, anlone and incombination, correlate with survival in young breast cancer patients. Nat Med, 1997,3:222-225.
  • 7McIntosh GG, Anderson JJ, Milton I, et al. Determination of the prognostic value of cyclin D1 overexpression in breast cancer. Oncogene, 1995,11:885-891.
  • 8Liaw D, Marsh DJ, Li J, et al. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat Genet, 1997,16:64-67.
  • 9Feeihoff D et al. Exclusion of a major role for the PTEN tunour-suppressor gene in breast cancinomas. Br J Cancer 1999,79:754-758.
  • 10Perren A, Weng LP, Boag AH, et al. Immunohistochemical evidence of loss of PTEN expression in primary ductal adenocarcinnomas of the breast. Am J Pathol, 1999,155:1253-1260.

共引文献46

同被引文献98

引证文献7

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部